ARCHIVES

CMS Allows Medicare Payment for Eloxatin, But Says Review of New Agents Likely

This article is from The Cancer Letter archive.

Vol. 29 No. 21 | May 23, 2003

Download PDF Visit The Full Archive

Related Articles

NIH, Myriad Talked About CRADA, Didn’t Agree, Varmus Writes

November 4, 1994

Corrections Made To NCI Phone Directory

May 17, 1991

In Brief: Holland Retires As Center Director, Replaced By NCI’s Aaronson; Lab Chiefs Leaving NCI

September 24, 1993

NIH, Lasker Foundation Offer Clinical Research Opportunity

December 10, 2010

Funding Opportunities: RFAs Available: NCI Challenge For Tumor Classification

February 5, 1999

In Brief: Ingell Vows To Broaden Indirect Cost Inquiry; Gallo, Fauci Make ‘Most Prolific Scientist’ List

February 7, 1992